Featured Products

Latest News

Mar

15

Liquid Biopsies for the Early Detection of Lung Cancer

The Fight Against Lung Cancer Developments in liquid biopsies provide significant implications in the advancement of care for patients with lung cancer. Lung cancer currently stands as the leading cause […]

See All News

We are ISO 9001 & 13485 Registered

Custom Sample Collection & Services

Product Release

BioChain launched CancerSeqPlus: NGS-characterized FFPE Tumor Samples. BioChain has leveraged NGS technologies to provide our customers with annotated reports of copy number variations (CNVs), single-nucleotide polymorphisms (SNPs), and insertions and deletion (indels) in clinically identified formalin fixed paraffin embedded (FFPE) tumor tissues.

See All Products

Who We Are

For over 20 yrs BioChain had been committed to empowering researcher with high quality biospecimens, tools for sample preparation and analysis, and bio-assays to accelerate the development and commercialization of diagnostics, therapeutics and medicine.

<
>